| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | P Marchetti | |
| G Lanzetta | |||
| G Minniti | |||
| R Maurizi Enrici | |||
| R Muni | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytotoxicity | Q246181 |
| glioblastoma | Q282142 | ||
| chemotherapy | Q974135 | ||
| P304 | page(s) | 5171-5184 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Anticancer Research | Q326290 |
| P1476 | title | Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents | |
| P478 | volume | 29 |
| Q64969067 | A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype. |
| Q34400848 | Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain |
| Q37644962 | Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes. |
| Q52730709 | Amentoflavone Induces Apoptosis and Inhibits NF-ĸB-modulated Anti-apoptotic Signaling in Glioblastoma Cells. |
| Q42365256 | Autophagy-related gene expression is an independent prognostic indicator of glioma |
| Q64915921 | Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis. |
| Q31016728 | Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival |
| Q28476714 | Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas |
| Q39354541 | Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma |
| Q36918752 | Chemotherapy for gliomas in mainland China: An overview |
| Q37099594 | Combining molecular targeted agents with radiation therapy for malignant gliomas |
| Q37137363 | Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes |
| Q26767169 | Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma |
| Q35229306 | Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells |
| Q37174083 | Diffusible Factors Secreted by Glioblastoma and Medulloblastoma Cells Induce Oxidative Stress in Bystander Neural Stem Progenitors |
| Q39035742 | Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth |
| Q36121398 | Estradiol induces JNK-dependent apoptosis in glioblastoma cells |
| Q34127138 | Experimental approaches for the treatment of malignant gliomas |
| Q58749539 | FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells |
| Q39481837 | Gambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cells |
| Q36698991 | Gene transfer for congestive heart failure: update 2013. |
| Q39045945 | Glioblastoma in the elderly: treatment patterns and survival |
| Q40698810 | Glioblastoma multiforme in the very elderly |
| Q33760539 | Gliomas in adults |
| Q47894479 | Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma |
| Q35063895 | Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway |
| Q38742022 | Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma |
| Q37226526 | Is glioblastoma an epigenetic malignancy? |
| Q58755619 | Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis |
| Q38613368 | LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair (MMR) pathway |
| Q38006702 | Long-term survival after gamma knife radiosurgery in a case of recurrent glioblastoma multiforme: a case report and review of the literature. |
| Q90168903 | Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration |
| Q92619583 | MiRNA-130a-3p inhibits cell proliferation, migration, and TMZ resistance in glioblastoma by targeting Sp1 |
| Q37694818 | MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma |
| Q37714896 | Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development |
| Q37819809 | Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier |
| Q42048668 | Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression |
| Q35041529 | Oncogene addiction in gliomas: implications for molecular targeted therapy |
| Q92665979 | Prognostic factors of patients with Gliomas - an analysis on 335 patients with Glioblastoma and other forms of Gliomas |
| Q35778723 | Proteomic analysis of glioma chemoresistance |
| Q47928337 | Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones. |
| Q35808894 | Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway |
| Q90148010 | Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells |
| Q33361853 | Role of Nitric Oxide in Glioblastoma Therapy: Another Step to Resolve the Terrible Puzzle ? |
| Q38697811 | Second primary glioblastoma multiforme following autologous hematopoietic stem cell transplantation in a patient with acute myelogenous leukemia |
| Q57793516 | Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy |
| Q92766550 | Synergistic combination of chemo‑phototherapy based on temozolomide/ICG‑loaded iron oxide nanoparticles for brain cancer treatment |
| Q38938545 | Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes. |
| Q36810416 | The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines. |
| Q54633298 | The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates. |
| Q91707540 | The role of interleukin-6-STAT3 signalling in glioblastoma |
| Q33757960 | The rs16906252:C>T SNP is not associated with increased overall survival or temozolomide response in a Han-Chinese glioma cohort |
| Q35027553 | Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK). |
| Q34402422 | Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1 |
| Q35086702 | hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence |
Search more.